Chris DelOrefice

Chief Financial Officer · Ulta Beauty

Beauty Products and Specialty Retail

Chris DelOrefice is Ulta Beauty’s CFO after senior finance leadership at Johnson & Johnson and Becton, Dickinson and Company.

Last reviewed: Oct 31, 2026

Chris DelOrefice

Chief Financial Officer
Ulta Beauty

Last Reviewed: October 31, 2026

Executive Summary

Chris DelOrefice is Ulta Beauty’s CFO after senior finance leadership at Johnson & Johnson and Becton, Dickinson and Company.

Career Highlights

  • Built finance experience at AstraZeneca, AET Films and Ametek before Johnson & Johnson.
  • Joined BD as executive vice president and CFO in September 2021.
  • Became Ulta Beauty CFO on December 5, 2025.

Professional Journey

DelOrefice’s early career included cost accounting, global audit and financial reporting leadership at AstraZeneca Pharmaceuticals, AET Films and Ametek. He then spent nearly two decades at Johnson & Johnson, building experience across corporate finance and operating businesses.

At J&J, his assignments included supply-chain finance, corporate mergers and acquisitions, consumer research and development, and pharmaceutical business development and contracting. He became CFO of the North American consumer and hospital medical-device businesses before serving as vice president of investor relations.

BD appointed him executive vice president and CFO effective September 6, 2021. He took responsibility for its global finance organization and subsequently added leadership of Technology and Global Services during a planned transition from predecessor Christopher Reidy.

DelOrefice moved to Ulta Beauty as CFO on December 5, 2025. He now oversees accounting, finance, tax, treasury, procurement, investor relations, internal audit and transformation. He also serves on ResMed’s board and chairs its audit committee, adding public-company oversight to his operating responsibilities.

Education

DelOrefice holds a BS in accounting and an MBA from Villanova University. His CPA credential is inactive.